Dow Up 0.00% Nasdaq Up 0.09%

Arena Pharmaceuticals, Inc. (ARNA)

-NasdaqGS
4.19 Up 0.07(1.70%) Nov 28, 1:00PM EST
Prev Close:4.12
Open:4.09
Bid:4.09 x 100
Ask:4.26 x 100
1y Target Est:7.58
Beta:-4.53
Earnings Date:Feb 25 - Mar 2 (Est.)
Day's Range:4.09 - 4.29
52wk Range:3.26 - 7.97
Volume:2,365,277
Avg Vol (3m):4,243,180
Market Cap:922.28M
P/E (ttm):N/A
EPS (ttm):-0.24
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ARNAUp 1.70%922.28M
GSKDown 0.15%111.67B
OREXDown 0.86%713.13M
RHHBYUp 0.13%254.54B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):26.44
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.24
Quarterly EPS Est (Dec-14) :-0.11
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):0.85

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors. The company offers BELVIQ, a drug used to treat chronic weight management in adults. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback